+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Latin America, Middle East & Africa Polymerase Chain Reaction (PCR) Market (2018 - 2024)

  • ID: 4721721
  • Report
  • November 2018
  • Region: Latin America, Middle East, Africa
  • 97 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Agilent Technologies
  • BioMérieux
  • Fluidigm Corporation
  • Hoffmann-La Roche Ltd
  • LGC Limited
  • Qiagen NV
  • MORE
The Latin America, Middle East and Africa Polymerase Chain Reaction Technologies Market is expected to witness market growth of 6.8% CAGR during the forecast period (2018 - 2024). Polymerase chain reaction technology devices are medical devices that are primarily used to generate thousands to millions of copies of a piece of deoxyribonucleic acid (DNA). These devices are majorly used in different life science fields such as genetics, molecular biology research, biotechnology, drug discovery, and clinical diagnostics. Growing geriatric population, growing prevalence of infectious diseases, rapidly growing diagnostic centers and hospitals, technological advancements, and growing awareness and acceptance of personalized medicine are the factors that drive the polymerase chain reaction technologies market. Nevertheless, growing non-validated home-brew tests and reimbursement issues are the factors that limit the growth of the market. Also, accuracy and timely results for RT-PCR is expected to further add to the challenges to the polymerase chain reaction technologies growth. Less tedious processes open avenues for the PCR market. Additionally, increasing funding towards research and development activities and large untapped markets in developing regions is expected to further add to the market opportunities during the forecast period.

Based on Technology, the market is segmented into Real Time PCR, Digital PCR and Traditional PCR. Based on Application, the market is segmented into Forensics, Research and Clinical. Based on Product, the market is segmented into Instruments, Reagents & consumables, Software and Services. Based on End user, the market is segmented into Biotech & Pharma Company, Diagnostics Centers & Hospitals and Academic & Research Institutions. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, BioMérieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd., Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., and Thermo Fisher Scientific.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agilent Technologies
  • BioMérieux
  • Fluidigm Corporation
  • Hoffmann-La Roche Ltd
  • LGC Limited
  • Qiagen NV
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Polymerase Chain Reaction (PCR) Market, by Technology
1.4.2 LAMEA Polymerase Chain Reaction (PCR) Market, by Application
1.4.3 LAMEA Polymerase Chain Reaction (PCR) Market, by Product
1.4.4 LAMEA Polymerase Chain Reaction (PCR) Market, by End User
1.4.5 LAMEA Polymerase Chain Reaction (PCR) Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.1.3 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Polymerase Chain Reaction Technologies Market by Technology
3.1.1 LAMEA Real-Time PCR Market by Country
3.1.2 LAMEA Digital PCR Market by Country
3.1.3 LAMEA Traditional PCR Market by Country

Chapter 4. LAMEA Polymerase Chain Reaction Technologies Market by Application
4.1.1 LAMEA Polymerase Chain Reaction Technologies in Forensics Market by Country
4.1.2 LAMEA Polymerase Chain Reaction Technologies in Research Market by Country
4.1.3 LAMEA Polymerase Chain Reaction Technologies in Clinical Market by Country

Chapter 5. LAMEA Polymerase Chain Reaction Technologies Market by Product
5.1.1 LAMEA Polymerase Chain Reaction Technologies Instruments Market by Country
5.1.2 LAMEA Polymerase Chain Reaction Technologies Reagents & Consumables Market by Country
5.1.3 LAMEA Polymerase Chain Reaction Technologies Software Market by Country
5.1.4 LAMEA Polymerase Chain Reaction Technologies Services Market by Country

Chapter 6. LAMEA Polymerase Chain Reaction Technologies Market by End User
6.1.1 LAMEA Polymerase Chain Reaction Technologies in Biotech & Pharma Companies Market by Country
6.1.2 LAMEA Polymerase Chain Reaction Technologies in Diagnostic Centers & Hospitals Market by Country
6.1.3 LAMEA Polymerase Chain Reaction Technologies in Academic & Research Institutions Market by Country

Chapter 7. LAMEA Polymerase Chain Reaction Technologies Market by Country
7.1 Brazil Polymerase Chain Reaction Technologies Market
7.1.1 Brazil Polymerase Chain Reaction Technologies Market by Technology
7.1.2 Brazil Polymerase Chain Reaction Technologies Market by Application
7.1.3 Brazil Polymerase Chain Reaction Technologies Market by Product
7.1.4 Brazil Polymerase Chain Reaction Technologies Market by End User
7.2 Argentina Polymerase Chain Reaction Technologies Market
7.2.1 Argentina Polymerase Chain Reaction Technologies Market by Technology
7.2.2 Argentina Polymerase Chain Reaction Technologies Market by Application
7.2.3 Argentina Polymerase Chain Reaction Technologies Market by Product
7.2.4 Argentina Polymerase Chain Reaction Technologies Market by End User
7.3 UAE Polymerase Chain Reaction Technologies Market
7.3.1 UAE Polymerase Chain Reaction Technologies Market by Technology
7.3.2 UAE Polymerase Chain Reaction Technologies Market by Application
7.3.3 UAE Polymerase Chain Reaction Technologies Market by Product
7.3.4 UAE Polymerase Chain Reaction Technologies Market by End User
7.4 Saudi Arabia Polymerase Chain Reaction Technologies Market
7.4.1 Saudi Arabia Polymerase Chain Reaction Technologies Market by Technology
7.4.2 Saudi Arabia Polymerase Chain Reaction Technologies Market by Application
7.4.3 Saudi Arabia Polymerase Chain Reaction Technologies Market by Product
7.4.4 Saudi Arabia Polymerase Chain Reaction Technologies Market by End User
7.5 South Africa Polymerase Chain Reaction Technologies Market
7.5.1 South Africa Polymerase Chain Reaction Technologies Market by Technology
7.5.2 South Africa Polymerase Chain Reaction Technologies Market by Application
7.5.3 South Africa Polymerase Chain Reaction Technologies Market by Product
7.5.4 South Africa Polymerase Chain Reaction Technologies Market by End User
7.6 Nigeria Polymerase Chain Reaction Technologies Market
7.6.1 Nigeria Polymerase Chain Reaction Technologies Market by Technology
7.6.2 Nigeria Polymerase Chain Reaction Technologies Market by Application
7.6.3 Nigeria Polymerase Chain Reaction Technologies Market by Product
7.6.4 Nigeria Polymerase Chain Reaction Technologies Market by End User
7.7 Rest of LAMEA Polymerase Chain Reaction Technologies Market
7.7.1 Rest of LAMEA Polymerase Chain Reaction Technologies Market by Technology
7.7.2 Rest of LAMEA Polymerase Chain Reaction Technologies Market by Application
7.7.3 Rest of LAMEA Polymerase Chain Reaction Technologies Market by Product
7.7.4 Rest of LAMEA Polymerase Chain Reaction Technologies Market by End User

Chapter 8. Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Revenue & Segment analysis
8.1.4 Research and Development
8.2 Bio-Rad Laboratories, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Thermo Fisher Scientific Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 bioMérieux SA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 Takara Bio Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Agilent Technologies
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Fluidigm Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.8 LGC Limited
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expense
8.9 Qiagen NV
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Expense
8.1 SYGNIS Pharma AG
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Agilent Technologies
  • BioMérieux
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd
  • Fluidigm Corporation
  • LGC Limited
  • Qiagen NV
  • SYGNIS Pharma AG
  • Takara Bio, Inc.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll